Samuel Olawale Olubode

ORCID, self-asserted

ORCID 0000-0002-7536-0604

Publications

Citations

159

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

15 works in the graph, newest first.

Multimodal Assessment of Ficus exasperata in Diabetic Drosophila
2025International Journal of Biological ChemistryJournalOpen access2 citations10.3923/ijbc.2025.36.61
α-Amylase Inhibitory Potential of Antidiabetes Ligands in Spondias Mombin Plant Extract: Molecular Docking and ADMET Profiling
2025Biological SciencesJournalOpen accessSenior author0 citations10.55006/biolsciences.2025.5102
Computational identification of potential modulators of heme-regulated inhibitor (HRI) for pharmacological intervention against sickle cell disease
2024Journal of Biomolecular Structure and DynamicsJournal4 citations10.1080/07391102.2024.2331097
A Computational Modeling Study on the Biomolecular Interactions of the Phytoconstituents of Nigella sativa with Anti-Apoptotic Proteins Mcl-1 and Bcl-x1
2024Asian Journal of Biochemistry Genetics and Molecular BiologyJournalOpen access1 citations10.9734/ajbgmb/2024/v16i7389
Structure-based scoring of anthocyanins and molecular modeling of PfLDH, PfDHODH, and PfDHFR reveal novel potential P. falciparum inhibitors
2023Informatics in Medicine UnlockedJournalOpen access20 citations10.1016/j.imu.2023.101206
Potential Inhibitory Biomolecular Interactions of Natural Compounds With Different Molecular Targets of Diabetes
2023Bioinformatics and Biology InsightsJournalOpen access17 citations10.1177/11779322231167970
Quantum evaluation and therapeutic activity of (E)-N-(4-methoxyphenyl)-2-(4-(3-oxo-3-phenylprop-1-en-1-yl) phenoxy)acetamide and its modified derivatives against EGFR and VEGFR-2 in the treatment of triple-negative cancer via in silico approach
2023Journal of Molecular ModelingJournal11 citations10.1007/s00894-023-05543-2
Design anticancer potential of Zn(II)isoleucinedithiocarbamate complex on MCF-7 cell lines: synthesis, characterization, molecular docking, molecular dynamic, ADMET, and in-vitro studies
2023Molecular DiversityJournal7 citations10.1007/s11030-023-10747-y
Identification of levomenthol derivatives as potential dipeptidyl peptidase-4 inhibitors: a comparative study with gliptins
2023Journal of Biomolecular Structure and DynamicsJournalOpen access6 citations10.1080/07391102.2023.2217927
Optimal molecular binding data and pharmacokinetic profiles of novel potential triple-action inhibitors of chymase, spleen tyrosine kinase, and prostaglandin D2 receptor in the treatment of asthma
2023Journal of Genetic Engineering and BiotechnologyJournalOpen access2 citations10.1186/s43141-023-00577-8
Molecular binding studies of anthocyanins with multiple antiviral activities against SARS-CoV-2
2022Bulletin of the National Research Centre/Bulletin of the National Research CenterJournalOpen access29 citations10.1186/s42269-022-00786-0
Molecular Modeling Studies of Natural Inhibitors of Androgen Signaling in Prostate Cancer
2022Cancer InformaticsJournalOpen accessFirst authorCorresponding22 citations10.1177/11769351221118556
Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment
2022Cancer InformaticsJournalOpen access13 citations10.1177/11769351221127862
A molecular modeling approach for structure-based virtual screening and identification of novel anti-hypercholesterolemic agents from Grape
2022Informatics in Medicine UnlockedJournalOpen access14 citations10.1016/j.imu.2022.101065
Computational evaluation of bioactive compounds from Vitis vinifera as a novel β-catenin inhibitor for cancer treatment
2022Bulletin of the National Research Centre/Bulletin of the National Research CenterJournalOpen accessSenior author11 citations10.1186/s42269-022-00872-3